American National Bank & Trust’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-500
Closed -$351 574
2024
Q1
$351 Hold
500
﹤0.01% 465
2023
Q4
$875 Hold
500
﹤0.01% 511
2023
Q3
$720 Hold
500
﹤0.01% 540
2023
Q2
$1.3K Hold
500
﹤0.01% 511
2023
Q1
$1.84K Hold
500
﹤0.01% 499
2022
Q4
$1K Hold
500
﹤0.01% 613
2022
Q3
$2K Hold
500
﹤0.01% 539
2022
Q2
$3K Hold
500
﹤0.01% 386
2022
Q1
$7K Hold
500
﹤0.01% 342
2021
Q4
$8K Hold
500
﹤0.01% 291
2021
Q3
$16K Hold
500
﹤0.01% 224
2021
Q2
$21K Hold
500
﹤0.01% 196
2021
Q1
$25K Sell
500
-1,000
-67% -$52.3K 0.01% 171
2020
Q4
$49K Hold
1,500
0.01% 137
2020
Q3
$18K Hold
1,500
0.01% 168
2020
Q2
$20K Buy
+1,500
New +$19.5K 0.01% 166

Other funds holding DMTK

American National Bank & Trust's DMTK Position: Q2 2024 in Review

American National Bank & Trust sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 500 shares — an estimated $351 sold.

American National Bank & Trust first reported a position in DMTK in Q2 2020 and held it in 16 quarters. The position peaked at $49K in Q4 2020. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • American National Bank & Trust reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • American National Bank & Trust sold 500 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $351.
  • American National Bank & Trust first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • American National Bank & Trust's DermTech, Inc. Common Stock position peaked at $49K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on American National Bank & Trust's 13F filing for Q2 2024, filed 23 Jul 2024.